Advanced Filters
noise
Found 1,651 clinical trials
A Anuradha V. Khadilkar, MBBS,MD

Effect of Micronutrient Supplementation on Nerve Conduction Velocity in T1D- RCT

Type 1 diabetes can complicate to peripheral neuropathy due to preferential involvement of small unmyelinated nerve fibers (pain and temperature sensation) followed by myelinated nerve fibers (vibration and proprioception). The SEARCH for diabetes in youth study found diabetic neuropathy in 7% of T1D youth. The clinical form of peripheral neuropathy …

10 - 22 years of age All Phase N/A
X Xia Li, MD/PHD

Safety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DM

This study is a prospective, single-center, parallel-design,1:1 randomized controlled trial with triple blinding. It aims to investigate the effects of fecal microbiota transplantation (FMT) on cognitive function in patients with long-term type 1 diabetes (T1D), as well as its effects on other complications, glycemic control, insulin dosage, insulin resistance, peripheral …

18 - 60 years of age All Phase N/A
E Elias Abou-Assaly, BA

Social Navigator to Address Social Determinants of Health in Pediatrics

It is crucial to understand the social and economic context in which children and youth live; their social determinants of health (SDH). Although this is well recognized, many health care providers do not address SDH because of the lack of easily accessible resources once social needs are identified. Social workers …

- 17 years of age All Phase N/A
P Pamela Martyn-Nemeth, PhD

Circadian Mechanisms, Glucose, and CV Risks in T1D

People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improving sleep regularity improves metabolic and cardiovascular health is not known. …

18 - 50 years of age All Phase N/A
X Xiaoming Pang, Doctor

Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection

This is a single-arm, open, investigator-initiated clinical study of CNK-UT009 cell injection in patients with type 1 diabetes. The purpose of this study is to evaluate the safety and tolerability of CNK-UT009 cell injection in patients with type 1 diabetes mellitus, determine the maximum tolerated dose (MTD), and evaluate the …

18 - 65 years of age All Phase N/A
T Tao Yang, PhD

Effect of Changes in Carbohydrate Intake Patterns on Glucose Control in Patients with Type 1 Diabetes

The blood glucose fluctuates greatly in T1DM patients, especially in the middle and late stages of the disease, and carbohydrate (CHO) is the main determinant of postprandial glucose response (PGR). Based on the previous investigation to understand how nutritional habits affect blood glucose control, we will conduct dietary intervention studies …

18 - 70 years of age All Phase N/A

Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and …

13 - 21 years of age All Phase N/A
N Nan Gu

Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients

In this study, type 1 diabetes patients from the outpatient department of Peking University First Hospital were selected as the research objects. The investigators plan to recruit 150 participants. Using the course and teaching plan of "Take Control of My Life - Structured Education for Type 1 diabetes" issued by …

18 years of age All Phase N/A
J Julian Bjerrekær

A Trial of Three- and Seven-days Insulin Infusions Set

More and more children and adolescents are using diabetes devices attached to the skin. The attachment of infusions sets to the skin provoke allergenic or toxic eczema, the continous infusion of insulin provoke subcutaneous changes and prolonged wear time seems to increase the risk of these complication. On the other …

7 - 18 years of age All Phase N/A

Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

This is a single-centre, multiple cohort, open study.

18 - 65 years of age All Phase N/A

Simplify language using AI